An interventional study of Sulforaphane-rich Broccoli Sprout Extract and High Intensity Interval Treadmill Running in Immunometabolism, Mitochondrial Function, Bioenergetics and Inflammation, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 19 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-17.
Sponsored by University of British Columbia · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Inflammation by University of British Columbia — 2 open to participants now, 2 under way, none of them phase 3. Inflammation · University of British Columbia.
Among the 15 studies in Inflammation by University of British Columbia, this one is the 8th largest by planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2026, is one of 8 with no phase, and was the 15th registered.
3,545 studies on the registry are indexed under Inflammation; 650 are open to participants now.
Browse Inflammation studies →2 of the 15 studies in Inflammation by University of British Columbia are open now, in 1 country. Recruiting first, the newest first:
University of British Columbia · Sites in Canada
Ages 19–75 · Healthy volunteers
By country, each count listing its studies:
Of the 464 Inflammation studies recruiting now, 175 (38%) set no upper age limit and 208 (45%) stop at 75 or younger; 58 take children under 18; 166 take healthy volunteers.
This study: 19 Years to 35 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 2 · Phase 4 2
First in 2002; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 50 across 2,586 interventional studies indexed under Inflammation.
Median enrollment 31 across the 13 interventional studies, 93 across the 2 observational. Of the 9 that completed or were terminated, 1 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of British Columbia is the lead sponsor of 1,342 studies on the registry; 262 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Inflammation by University of British Columbia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The study consist of 3 interventional periods which will be completed by each consenting participant in a randomized, crossover fashion. The interventional periods will be separated by a minimum 1 week washout period. One of the interventions consists of 4 days of daily supplementation with the commercially available broccoli sprout extract capsules (BrocElite). Another intervention will consist of 4 days of daily supervised treadmill running. The exercise protocol consists of 4 minutes of high-intensity running running followed by a 3 minute recovery period, repeated for a total of 4 repetitions. The last intervention combines the above two and consists of 4 days of daily supplementation and daily supervised exercise training. Before and after each intervention, basic anthropometrics (weight, heart rate, and blood pressure) will be recorded, and a venous blood sample will be collected. Blood samples will be analyzed for metabolic and inflammatory markers. Participants will be asked to refrain from structured exercise, alcohol consumption, and broccoli consumption during each of the experimental periods. Before any testing, willing participants will provide informed consent, and fill out a few demographic, and lifestyle questionnaires. The study will be conducted at the University of British Columbia in Kelowna, BC, Canada.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In this intervention, participants will consume commercially available broccoli sprout extract capsules daily for 4 days (20 mg/day) . Basic anthropometrics (weight, heart rate, blood pressure) and a venous blood sample (30 mL) will be collected before and after this interventional period.
Dietary Supplement: Sulforaphane-rich Broccoli Sprout Extract
In this intervention, participants will complete supervised exercise sessions daily for 4 days. The exercise intervention consists of interval running on a treadmill which contains 4 cycles of: 4 minutes of intense running (85-95% HRmax) followed by 3 minutes at a slow, easy pace. Basic anthropometrics (weight, heart rate, blood pressure) and a venous blood sample (30 mL) will be collected before and after this interventional period.
Other: High Intensity Interval Treadmill Running
In this intervention, participants will consume commercially available broccoli sprout extract tablets daily for 4 days. In addition, participants will complete supervised exercise sessions daily for 4 days. The exercise intervention consists of interval running on a treadmill which contains 4 cycles of: 4 minutes of intense running (85-95% HRmax) followed by 3 minutes at a slow, easy pace. Basic anthropometrics (weight, heart rate, blood pressure) and a venous blood sample (30 mL) will be collected before and after this interventional period.
Dietary Supplement: Sulforaphane-rich Broccoli Sprout Extract · Other: High Intensity Interval Treadmill Running
Broc Elite Plus stabilized sulforaphane capsules from Mara Labs
4 cycles of: 4 minutes of intense treadmill running (85-95% HR max) followed by 3 minutes of slow, easy running.
Change in peripheral blood mononuclear cell oxygen consumption rate
OCR will be measured using a Seahorse Analyzer before and after each 4-day intervention
Time frame: 0-4 days
TNF-alpha secretion from LPS-stimulated whole blood
TNF-alpha secretion from LPS-stimulated whole blood will be measured via ELISA before and after each 4-day period
Time frame: 0-4 days
Change in percentage of classical monocytes before and after the 6-week intervention
The percentage of classical monocytes will be measured using flow cytometry at baseline and after the 4-day intervention
Time frame: 0-4 days
Change in percentage of intermediate monocytes before and after the 4-day intervention
The percentage of intermediate monocytes will be measured using flow cytometry at baseline and after the 4-day intervention
Time frame: 0-4 days
Change in percentage of non-classical monocytes before and after the 4-day intervention
The percentage of non-classical monocytes will be measured using flow cytometry at baseline and after the 4-day intervention
Time frame: 0-4 days
Change in TLR-4 expression on classical monocytes before and after the 4-day intervention
TLR-4 expression on classical monocytes will be measured using flow cytometry at baseline and after the 4-day intervention.
Time frame: 0-4 days
Change in TLR-4 expression on intermediate monocytes before and after the 4-day intervention
TLR-4 expression on intermediate monocytes will be measured using flow cytometry at baseline and after the 4-day intervention.
Time frame: 0-4 days
Change in TLR-4 expression on non-classical monocytes before and after the 4-day intervention
TLR-4 expression on non-classical monocytes will be measured using flow cytometry at baseline and after the 4-day intervention
Time frame: 0-4 days
Change in white blood cell counts before and after the 4-day intervention
White blood cell counts will be measured using a hematology analyzer at baseline and after the 4-day intervention
Time frame: 0-4 days
TNF-alpha secretion from PolyIC-stimulated whole blood
TNF-alpha secretion from PolyIC-stimulated whole blood will be measured via ELISA before and after each 4-day period
Time frame: 0-4 days
Change in peripheral blood mononuclear cell extracellular acidification rate before and after the 4-day period
PBMC ECAR will be measured using a Seahorse Analyzer at baseline and after the 4-day intervention
Time frame: 0-4 days
Change in PBMC mitotracker green staining before and after the 4-day period
PBMC mitotracker green will be measured using flow cytometry before and after the 4-day intervention period
Time frame: 0-4 days
Change in PBMC mitoSOX red staining before and after the 4-day period
PBMC mitoSOX red will be measured using flow cytometry before and after the 4-day intervention period
Time frame: 0-4 days
Change in PBMC mitochondrial respiration before and after the 4-day intervention period
PBMC mitochondrial respiration will be measured using high-resolution respirometry before and after the 4-day period
Time frame: 0-4 days
Plan to share: No — IPD will not be shared to ensure the privacy and confidentiality of participants, in accordance with ethical guidelines and data protection regulations. Additionally, this was not included in the informed consent, which did not cover data sharing or address potential risks of re-identification.
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Dec 2027, 21 months after the start.
Of 882 non-industry interventional studies with no phase under Inflammation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 21 months is above that.
Counting every sponsor, half of 929 studies reached it within 17 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia →